AI-assisted scope test for detecting pancreatic growths
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether an artificial intelligence (AI) system can help doctors spot abnormal or cancerous growths in the pancreas during a special endoscopic procedure called pancreatoscopy. If successful, it could improve the accuracy of detecting these growths and help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a procedure called per-oral pancreatoscopy (a scope that looks inside your pancreas) for diagnosis or before surgery.
- You have a suspected or known type of pancreatic cyst called IPMN, or an unclear narrowing or blockage in the main pancreatic duct.
- You are able to undergo the procedure and provide written consent.
- You are willing to attend a follow-up visit at 6 months if the doctor doesn't take a tissue sample during the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze tissue samples from pancreatic cancer to help predict how the disease may progress. It aims to improve treatment planning and patient care.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This study tests whether an AI tool can help doctors perform and learn pancreatic ultrasound exams better. If you need a pancreas ultrasound, you may be able to join.
This trial uses a new, faster method to diagnose solid pancreatic tumors during an endoscopic ultrasound procedure. It combines rapid staining of cells with artificial intelligence to give a quick and accurate diagnosis.
This study tests how well an AI tool can guide which pre-surgery treatment is best for people with pancreatic cancer that can be removed. It uses your tumor's genetic fingerprint to choose the most effective therapy.
This trial tests a new computer (deep-learning) system to help analyze pictures from an endoscopic ultrasound scan of the pancreas. It may improve how the scan is done or interpreted, depending on study results.
Hear when a new Intraductal Papillary Mucinous Neoplasm of Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.